icon-    folder.gif   Conference Reports for NATAP  
  20th International AIDS Conference
July 20-25, 2014
Melbourne, Australia
Back grey_arrow_rt.gif
Open label, randomized, crossover, single-dose, bioavailability evaluation of atazanavir/ritonavir FDC tablets 300 mg/100 mg with that of REYATAZ 300 mg and NORVIR 100 mg under fed and fasting conditions
  Reported by Jules Levin
20th International AIDS Conference, July 20-25, 2014, Melbourne
I. Bhushan1, A. Deshmukh1, S. Chakraborty1, A. Dixit1, P. Shetiya1, U. Kothawade1, A. Kanda2,
P. Deshpande2, E. Patras2, R. Satapthy1
1MYLAN Laboratories Ltd., Research & Development, Hyderabad, India 2MYLAN Laboratories Ltd., Business Development, Hyderabad, India